Eric Hajjar

20y+ Experience in Drug Development, from Preclinical to Approval, Medical, Access, Innovation and Digital.
Customer obsession and business focused with track record of delivering above target.
Strong analytical and interpersonal skills including leadership experience.
Excel in matrix & team management and drive change in dynamic environments.
Committed to continuous learning and a passion for fostering a positive culture of innovation.

Robina Weermeijer

Patient & Site Engagement Lead focused on representation in clinical trials at Boehringer Ingelheim, passionate about transforming healthcare. With 10+ years of experience in the pharmaceutical industry, I connect and collaborate with patients & healthcare professionals worldwide, to help make our clinical trials more accesible. Let’s work together to make clinical research more inclusive!

Pilar de la Rocha Mur

Global Drug Development Executive | Board Member | Founder
Strategic Leader in Oncology and Global Clinical Operations.
22+ Years Building and Governing High-Impact Teams Across 6 Continents
Driving Innovation, Scale, and Long-Term Enterprise Value

Lidia Magielska

Global clinical trials, teams leader with extensive experience in pharmaceutical business. Innovative, agile, proactive mindset with hands on experience in leading multiply projects, teams and people development. Cross department knowledge with business acumen. Project management of global clinical trials, site management and monitoring, CRO management. Line management, coaching, leadership. Pharmaceutical sales & marketing with projects delivery for generic and innovative products with proven achievements track. Working experience in clinical trial management in China.
Passionate about medicines development, strategic management and multicultural environment.
Interested in new solutions and innovation in project and program management in clinical trials with a global scope.

Juliet Dizon

I am a Clinical Research professional with more than 20 years of combined experience across the pharmaceutical, biotechnology, and medical devices industries. My background includes 17 years as a Quality Professional in Switzerland and 3 years in Singapore where I managed clinical monitoring and operations, directly overseen drug-device combination trials across 13 Asia-Pacific countries including Japan, Australia/New Zealand, China, Japan, South Korea, India, and others.

I am a highly skilled Quality Professional with focus on Quality Assurance, end to end Quality Strategy, Risk Management and Compliance. Recognized for work ethics and passionate leadership. Strategic and with extensive experience driving global pharmaceutical development and regulatory success. Expert in integrating end-to-end quality principles across cross-functional R&D programs and implementing Quality by Design (QbD) aided by data analytics.

Specializing in GCP, GLP, GMP, Pharmacovigilance (GVP), and Computerized System Validation (CSV). Led global audits, inspection readiness, and Health Authority inspections for high-priority NDAs. Expertise in Risk-Based Quality Management, Quality Strategy, Quality Narratives and regulatory compliance across major global health authorities.

An empathetic People Leader who champions growth and development of team members to help them reach their full potentials, mentored cross functional teams and coached direct reports globally, recognised for stakeholder engagement and effective collaboration across diverse, multi-cultural environment in both big pharma and start-up biotechnology environments.

Kurt Hartlen

Kurt Hartlen has worked for Imperial Oil since 2010. I am passionate about solving problems and supporting customers. Kurt has experience in used oil analysis, product development, and technicals support. Currently Kurt is a Sales and Field Technical Advisor in Canada and is part of ExxonMobil’s Global Wind Team.